The latest announcement is out from ReShape Lifesciences ( (RSLS) ).
On March 14, 2025, Gary Blackford announced his resignation from the Board of Directors and all related committees of ReShape Lifesciences Inc., effective March 15, 2025. His departure leaves the company’s Audit Committee with only two independent directors, thereby temporarily breaching Nasdaq’s listing requirements, though the company plans to use the allowed cure period to address this issue.
More about ReShape Lifesciences
ReShape Lifesciences Inc. operates in the medical device industry, focusing on products and services related to weight loss and metabolic health.
YTD Price Performance: -86.18%
Average Trading Volume: 1,183,079
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.11M
See more insights into RSLS stock on TipRanks’ Stock Analysis page.